About This Deal

BAXTER INTERNATIONAL INC acquired Epic Therapeutics, Inc. for $59M, a transaction completed in November 2002, structured as Acquisition of a drug-delivery technology company.

Epic Therapeutics, Inc. operates in Medication Delivery, is based in United States. Baxter acquired Epic Therapeutics, a drug-delivery company specializing in the formulation of drugs for injection or inhalation, including controlled-release protein therapeutics using its proprietary PROMAXX microsphere technology. The acquisition strengthened Baxter's drug-delivery portfolio.

Added the PROMAXX microsphere drug-formulation technology for injectable and inhaled controlled-release therapeutics.

Deal Terms

Acquirer
BAXTER INTERNATIONAL INC
Target
Epic Therapeutics, Inc.
Value
$59M
Date
November 2002
Type
Acquisition
Status
Ready

Transaction Details

Target HQ
United States
Segment
Medication Delivery
Structure
Acquisition of a drug-delivery technology company
Closed
November 2002

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: SEC filing ↗

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.